Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| RGNX | Regenxbio | $6.25 | -$3.79 | -37.75% | 511.8K | $518M | $6.02$16.19 |
| HCAI | Huachen Ai Parking Management Technology | $6.50 | -$3.36 | -34.08% | 89.5K | $11M | $3.96$318.00 |
| ENHA | Enhanced | $4.03 | -$1.25 | -23.67% | 612.9K | $144M | $3.98$14.00 |
| DOCS | Doximity | $17.99 | -$5.40 | -23.09% | 1.2M | $4.3B | $17.15$76.51 |
| RVI | Robinhood Ventures Fund I | $57.15 | -$16.57 | -22.47% | 3.9M | $930M | $21.00$77.39 |
| MEI | Methode Electronics | $10.96 | -$2.92 | -21.02% | 3M | $491M | $4.88$15.55 |
| ERNA | Ernexa Therapeutics | $9.92 | -$2.22 | -18.29% | 430.3K | $14M | $3.18$93.75 |
| LWLG | Lightwave Logic | $14.89 | -$3.33 | -18.25% | 15.8M | $2.7B | $0.92$18.71 |
| LIVE | Live Ventures | $11.26 | -$2.49 | -18.11% | 42.9K | $42M | $7.01$25.42 |
| NIQ | Niq Global Intelligence Plc | $8.29 | -$1.75 | -17.39% | 3.8M | $3.0B | $8.26$21.00 |
| JACK | Jack In The Box | $10.59 | -$2.20 | -17.19% | 2.3M | $243M | $8.92$25.34 |
| LIDR | AEye | $2.02 | -$0.42 | -17.08% | 60.6K | $110M | $0.66$6.44 |
| ALMU | Aeluma | $26.15 | -$5.35 | -16.97% | 4.8M | $567M | $10.20$31.79 |
| BTGO | Bitgo | $9.90 | -$2.01 | -16.88% | 53.6K | $1.4B | $7.25$24.50 |
| INVE | Identiv | $4.02 | -$0.80 | -16.60% | 427K | $116M | $3.03$5.30 |
| ISSC | Innovative Aerosystems | $17.28 | -$3.32 | -16.10% | 2.1M | $366M | $8.13$30.94 |
| PYXS | Pyxis Oncology | $2.22 | -$0.40 | -15.27% | 35.8K | $165M | $0.97$5.55 |
| AIRO | Airo Group | $6.64 | -$1.19 | -15.20% | 48.2K | $246M | $6.12$39.07 |
| SKK | Skk | $3.49 | -$0.52 | -12.88% | 171K | $9.8M | $1.61$17.95 |
Related Articles
Featured Article
Jack in the Box's Revenue and Sales Are Down. Here Are 3 Key Takeaways From Its Latest Earnings.
Dave Kovaleski|Feb 26, 2026
It was another brutal quarter for Jack in the Box.
Should You Buy This Stock After It Skyrocketed by 33%?
Prosper Junior Bakiny|Aug 25, 2024
It's a welcome sight for shareholders who haven't had much to rejoice about lately.
2 No-Brainer Growth Stocks Down 29% and 22% to Buy Hand Over Fist Right Now
Rachel Warren|May 14, 2024
These businesses are generating strong momentum, despite what share prices might indicate.
1 Cash-Gushing Stock Down 70% to Buy and Hold Forever
Josh Kohn-Lindquist|Feb 21, 2024
This healthcare upstart, with a free-cash-flow margin of 27% even after removing stock-based compensation, deserves a long look from investors.
2 Magnificent Stocks That Could Go Parabolic
Josh Kohn-Lindquist|Dec 2, 2023
Down 41% and 53% from their 52-week highs, these two market-leading stocks are primed for a rebound.
The Top Healthcare Stocks to Buy With $100
Prosper Junior Bakiny|Oct 28, 2023
You can invest on a budget and still be successful at it.
1 Growth Stock Down 39% to Buy and Hold for 10 Years
Prosper Junior Bakiny|Sep 25, 2023
This stock could eventually bounce back. Don't wait until then before buying shares.
This Is the Biggest Problem With Doximity's Stock
David Jagielski, CPA|Aug 24, 2023
The stock is near its 52-week low but it definitely isn't cheap.
1 Growth Stock Down Nearly 40% to Buy and Hold For 10 Years
Prosper Junior Bakiny|Aug 16, 2023
The company's shares recently dropped following its latest quarterly update.
Down 39.9%, Is Doximity a Buy on the Dip?
Cory Renauer|Aug 14, 2023
Find out if everyday investors should be as upset about the company's outlook revision as Wall Street was.
